Drug profile · INN
fosamprenavir calcium
FOSAMPRENAVIR CALCIUM
fosamprenavir calcium (FOSAMPRENAVIR CALCIUM) is a human immunodeficiency virus type 1 protease inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — fosamprenavir calcium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
fosamprenavir calcium (FOSAMPRENAVIR CALCIUM) is a human immunodeficiency virus type 1 protease inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Human immunodeficiency virus type 1 protease inhibitor
Primary target: Human immunodeficiency virus type 1 protease
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fosamprenavir calcium?
fosamprenavir calcium (FOSAMPRENAVIR CALCIUM) is a human immunodeficiency virus type 1 protease inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fosamprenavir calcium?
FOSAMPRENAVIR CALCIUM is a marketed brand name for fosamprenavir calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fosamprenavir calcium?
fosamprenavir calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.